Structure- and cell-specific effects of imidoselenocarbamates on selenoprotein expression and activity in liver cells in culture

Metallomics

Volumn 4, Issue 12, 2012, Pages 1297-1307

  Ibáñez, Elena ^a   Stoedter, Mette ^b   Hofmann, Peter Josef ^b   Plano, Daniel ^a   Calvo, Alfonso ^c   Nguewa, Paul A ^c   Palop, Juan Antonio ^a   Sanmartín, Carmen ^a   Schomburg, Lutz ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL EFFECTS; CANCER CELLS; ER STRESS; GLUTATHIONE PEROXIDASE; HEPATIC CARCINOMA; HEPATOCARCINOMA; HEPATOCYTES; HEPG2 CELLS; IN-VITRO; LIVER CELLS; MOUSE TUMORS; SELENOCOMPOUNDS; SELENOENZYMES; SELENOPROTEIN EXPRESSION; SELENOPROTEIN P; SELENOPROTEINS; STRESS RESPONSE; THIOREDOXIN REDUCTASE; UNFOLDED PROTEIN RESPONSE; UNIQUE SPECTRA;

BIOCHEMISTRY; CELL CULTURE; CELL PROLIFERATION; PHYSIOLOGICAL MODELS; PHYSIOLOGY; SELENIUM; TRACE ELEMENTS;

CELLS;

ACTIN; BENZYL DERIVATIVE; CARBAMIC ACID DERIVATIVE; GLUCOSE REGULATED PROTEIN 94; GLUTATHIONE PEROXIDASE; IMIDOSELENOCARBAMATE DERIVATIVE; METHYL GROUP; SELENIUM; SELENIUM DERIVATIVE; SELENOPROTEIN; SELENOPROTEIN P; THIOREDOXIN PEROXIDASE; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SPECIFICITY; CELL STRAIN AML12; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG STRUCTURE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; UNFOLDED PROTEIN RESPONSE;

ANTINEOPLASTIC AGENTS; ENDOPLASMIC RETICULUM STRESS; GLUTATHIONE PEROXIDASE; HEP G2 CELLS; HEPATOCYTES; HUMANS; MEMBRANE PROTEINS; ORGANOSELENIUM COMPOUNDS; SELENOPROTEIN P; SELENOPROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; THIOREDOXIN-DISULFIDE REDUCTASE; UNFOLDED PROTEIN RESPONSE;

EID: 84870013374     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c2mt20096a     Document Type: Article

References (57)

1. B. J. Goldstein K. Mahadev X. Wu L. Zhu H. Motoshima Role of insulin-induced reactive oxygen species in the insulin signaling pathway Antioxid. Redox Signaling 2005 7 1021 1031
2. J. M. Mates F. Sanchez-Jimenez Antioxidant enzymes and their implications in pathophysiologic processes Front. Biosci. 1999 4 D339 D345
3. S. J. Ross V. J. Findlay P. Malakasi B. A. Morgan Thioredoxin peroxidase is required for the transcriptional response to oxidative stress in budding yeast Mol. Biol. Cell 2000 11 2631 2642
4. G. V. Smirnova N. G. Muzyka M. N. Glukhovchenko O. N. Oktyabrsky Effects of menadione and hydrogen peroxide on glutathione status in growing Escherichia coli Free Radical Biol. Med. 2000 28 1009 1016
5. H. Sies Biochemistry of oxidative stress Angew. Chem., Int. Ed. Engl. 1986 25 1058 1071
6. B. Halliwell Oxidants and human disease: some new concepts FASEB J. 1987 1 358 364
7. H. Sies Oxidative stress: from basic research to clinical application Am. J. Med. 1991 91 31S 38S
8. S. Zhang C. Rocourt W. H. Cheng Selenoproteins and the aging brain Mech. Ageing Dev. 2010 131 253 260
9. P. Storz Reactive oxygen species in tumor progression Front. Biosci. 2005 10 1881 1896
10. R. Brigelius-Flohe A. Kipp Glutathione peroxidases in different stages of carcinogenesis Biochim. Biophys. Acta 2009 1790 1555 1568
11. P. A. Cerutti Prooxidant states and tumor promotion Science 1985 227 375 381
12. J. T. Pinto J. I. Lee R. Sinha M. E. MacEwan A. J. Cooper Chemopreventive mechanisms of alpha-keto acid metabolites of naturally occurring organoselenium compounds Amino Acids 2011 41 29 41
13. R. Sinha K. El-Bayoumy Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds Curr. Cancer Drug Targets 2004 4 13 28
14. R. Abdulah K. Miyazaki M. Nakazawa H. Koyama Chemical forms of selenium for cancer prevention J. Trace Elem. Med. Biol. 2005 19 141 150
15. C. Ip M. Birringer E. Block M. Kotrebai J. F. Tyson P. C. Uden D. J. Lisk Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention J. Agric. Food Chem. 2000 48 4452
16. P. D. Whanger Selenium and its relationship to cancer: an update Br. J. Nutr. 2004 91 11 28
17. J. Hesketh Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics Annu. Rev. Nutr. 2008 28 157 177
18. M. P. Rayman Selenoproteins and human health: insights from epidemiological data Biochim. Biophys. Acta 2009 1790 1533 1540
19. Y. Chen W. Maret Catalytic selenols couple the redox cycles of metallothionein and glutathione Eur. J. Biochem. 2001 268 3346 3353
20. C. H. Lillig A. Holmgren Thioredoxin and related molecules - from biology to health and disease Antioxid. Redox Signaling 2007 9 25 47
21. U. Singh K. Null R. Sinha In vitro growth inhibition of mouse mammary epithelial tumor cells by methylseleninic acid: involvement of protein kinases Mol. Nutr. Food Res. 2008 52 1281 1288
22. E. Unni D. Koul W. K. Yung R. Sinha Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro Breast Cancer Res. 2005 7 R699 R707
23. H. Zeng M. Wu J. H. Botnen Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes J. Nutr. 2009 139 1613 1618
24. E. Ibanez A. Agliano C. Prior P. Nguewa M. Redrado I. Gonzalez-Zubeldia D. Plano J. A. Palop C. Sanmartin A. Calvo The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity Curr. Med. Chem. 2012 19 3031 3043
25. H. E. Ganther Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase Carcinogenesis 1999 20 1657 1666
26. S. Gromer J. H. Gross Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium J. Biol. Chem. 2002 277 9701 9706
27. J. E. Spallholz B. J. Shriver T. W. Reid Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of l-selenomethionine and l-Se-methylselenocysteine Nutr. Cancer 2001 40 34 41
28. C. S. Hoefig K. Renko J. Kohrle M. Birringer L. Schomburg Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture J. Nutr. Biochem. 2011 22 945 955
29. M. Wu M. M. Kang N. W. Schoene W. H. Cheng Selenium compounds activate early barriers of tumorigenesis J. Biol. Chem. 2010 285 12055 12062
30. M. P. Rayman Selenium in cancer prevention: a review of the evidence and mechanism of action Proc. Nutr. Soc. 2005 64 527 542
31. E. Ibanez D. Plano M. Font A. Calvo C. Prior J. A. Palop C. Sanmartin Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates Eur. J. Med. Chem. 2011 46 265 274
32. C. Riese M. Michaelis B. Mentrup F. Gotz J. Kohrle U. Schweizer L. Schomburg Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues Endocrinology 2006 147 5883 5892
33. L. Schomburg U. Schweizer B. Holtmann L. Flohe M. Sendtner J. Kohrle Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues Biochem. J. 2003 370 397 402
34. B. Hollenbach N. G. Morgenthaler J. Struck C. Alonso A. Bergmann J. Kohrle L. Schomburg New assay for the measurement of selenoprotein P as a sepsis biomarker from serum J. Trace Elem. Med. Biol. 2008 22 24 32
35. K. Renko P. J. Hofmann M. Stoedter B. Hollenbach T. Behrends J. Kohrle U. Schweizer L. Schomburg Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice FASEB J. 2009 23 1758 1765
36. A. Samali U. Fitzgerald S. Deegan S. Gupta Methods for monitoring endoplasmic reticulum stress and the unfolded protein response Int. J. Biochem. Cell Biol. 2010 2010 830307
37. K. E. Hill J. Zhou W. J. McMahan A. K. Motley J. F. Atkins R. F. Gesteland R. F. Burk Deletion of selenoprotein P alters distribution of selenium in the mouse J. Biol. Chem. 2003 278 13640 13646
38. J. C. Wu G. Merlino N. Fausto Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha Proc. Natl. Acad. Sci. U. S. A. 1994 91 674 678
39. M. Alanne K. Kristiansson K. Auro K. Silander K. Kuulasmaa L. Peltonen V. Salomaa M. Perola Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts Hum. Genet. 2007 122 355 365
40. J. E. Curran J. B. Jowett K. S. Elliott Y. Gao K. Gluschenko J. Wang D. M. Abel Azim G. Cai M. C. Mahaney A. G. Comuzzie T. D. Dyer K. R. Walder P. Zimmet J. W. MacCluer G. R. Collier A. H. Kissebah J. Blangero Genetic variation in selenoprotein S influences inflammatory response Nat. Genet. 2005 37 1234 1241
41. M. Olsson B. Olsson P. Jacobson D. S. Thelle J. Bjorkegren A. Walley P. Froguel L. M. Carlsson K. Sjoholm Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors Metab., Clin. Exp. 2011 60 114 120
42. K. H. Kim Y. Gao K. Walder G. R. Collier J. Skelton A. H. Kissebah SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis Biochem. Biophys. Res. Commun. 2007 354 127 132
43. M. Stoedter K. Renko A. Hog L. Schomburg Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice Biochem. J. 2010 429 43 51
44. M. Marzec D. Eletto Y. Argon GRP94: an HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum Biochim. Biophys. Acta 2012 1823 774 787
45. C. Hetz J. Castilla C. Soto Perturbation of endoplasmic reticulum homeostasis facilitates prion replication J. Biol. Chem. 2007 282 12725 12733
46. M. Ni A. S. Lee ER chaperones in mammalian development and human diseases FEBS Lett. 2007 581 3641 3651
47. J. R. Arthur The glutathione peroxidases Cell. Mol. Life Sci. 2000 57 1825 1835
48. K. E. Hill P. R. Lyons R. F. Burk Differential regulation of rat liver selenoprotein mRNAs in selenium deficiency Biochem. Biophys. Res. Commun. 1992 185 260 263
49. X. G. Lei J. K. Evenson K. M. Thompson R. A. Sunde Glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase are differentially regulated in rats by dietary selenium J. Nutr. 1995 125 1438 1446
50. L. Bjorkhem H. Teclebrhan E. Kesen J. M. Olsson L. C. Eriksson M. Bjornstedt Increased levels of cytosolic thioredoxin reductase activity and mRNA in rat liver nodules J. Hepatol. 2001 35 259 264
51. E. H. Chew J. Lu T. D. Bradshaw A. Holmgren Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity FASEB J. 2008 22 2072 2083
52. E. S. Arner A. Holmgren The thioredoxin system in cancer Semin. Cancer Biol. 2006 16 420 426
53. J. E. Biaglow R. A. Miller The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy Cancer Biol. Ther. 2005 4 6 13
54. G. Fujino T. Noguchi K. Takeda H. Ichijo Thioredoxin and protein kinases in redox signaling Semin. Cancer Biol. 2006 16 427 435
55. A. K. Rundlof E. S. Arner Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events Antioxid. Redox Signaling 2004 6 41 52
56. J. K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 2004 10 Suppl S18 S25
57. L. Schomburg U. Schweizer Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium Biochim. Biophys. Acta 2009 1790 1453 1462